MPLT vs SPG · $1.24B cap vs rev $3.55B
MapLight Therapeutics, Inc. Common Stock (MPLT) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
SPG (SPG) common stock.
MPLT does not have a complete income-statement cache yet.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
MPLT currently screens at market cap $1.24B. SPG currently screens at market cap $0.
Not investment advice. Open the MPLT and SPG stock pages for the full models.
Not investment advice.